Klaus Kopka
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Radiopharmaceutical Chemistry and Applications 152
- Medical Imaging Techniques and Applications 51
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research 96
- Prostate Cancer Diagnosis and Treatment 25
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 60
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 24
- Spectroscopy top 1%
- Mass Spectrometry Techniques and Applications 18
-
- Receptor Mechanisms and Signaling 19
- Co-authors
- Uwe HaberkornClemens KratochwilFrederik L. GieselMatthias EderAli Afshar‐OromiehWalter MierMartin SchäferMartina Benešová
- Journals
- Journal of the American Chemical Society (1 paper)Circulation (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Klaus Kopka
273 papers receiving 12.9k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Radiology, Nuclear Medicine and Imaging 8.8k
- Pulmonary and Respiratory Medicine 8.2k
- Oncology 3.4k
- Cancer Research 1.4k
- Spectroscopy 808
Countries citing papers authored by Klaus Kopka
This map shows the geographic impact of Klaus Kopka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Kopka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Kopka more than expected).
Fields of papers citing papers by Klaus Kopka
This network shows the impact of papers produced by Klaus Kopka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Kopka. The network helps show where Klaus Kopka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Klaus Kopka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 21 | |
| 15 | 2021 | 27 | |
| 16 | 2020 | 7 | |
| 17 | 2020 | 24 | |
| 18 | 2019 | 49 | |
| 19 | 2019 | 4 | |
| 20 | 2019 | 6 |
About Klaus Kopka
Klaus Kopka is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 284 papers that have together received 13.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (152 papers), Prostate Cancer Treatment and Research (96 papers), Peptidase Inhibition and Analysis (60 papers), Medical Imaging Techniques and Applications (51 papers), Prostate Cancer Diagnosis and Treatment (25 papers), Protease and Inhibitor Mechanisms (24 papers), Receptor Mechanisms and Signaling (19 papers) and Mass Spectrometry Techniques and Applications (18 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (8.8k citations), Pulmonary and Respiratory Medicine (8.2k citations) and Oncology (3.4k citations). Klaus Kopka has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Uwe Haberkorn, Clemens Kratochwil, Frederik L. Giesel, Matthias Eder, Ali Afshar‐Oromieh, Walter Mier, Martin Schäfer, Martina Benešová, Boris Hadaschik and Michael Schäfers. Their work appears in journals such as Journal of the American Chemical Society, Circulation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.